Cathepsin B is essential for regeneration of scratch-wounded normal human epidermal keratinocytes.
暂无分享,去创建一个
Raluca Ostafe | P. Boukamp | K. Brix | Maren Rehders | R. Ostafe | Heiko Büth | N. Schaschke | Petra Boukamp | Hans-Jürgen Stark | Klaudia Brix | Heiko Büth | Pier Luigi Buttigieg | Maren Rehders | Stefanie R Dannenmann | Norbert Schaschke | S. Dannenmann | H. Stark | Pier Luigi Buttigieg
[1] G. Vaes,et al. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. , 1977, The Biochemical journal.
[2] P. Henkart,et al. Surface Cathepsin B Protects Cytotoxic Lymphocytes from Self-destruction after Degranulation , 2002, The Journal of experimental medicine.
[3] A. Singer,et al. Cutaneous wound healing. , 1999, The New England journal of medicine.
[4] N. Fusenig,et al. Differential stromal regulation of MMP-1 expression in benign and malignant keratinocytes. , 2001, The Journal of investigative dermatology.
[5] G. Kirfel,et al. Migration of epidermal keratinocytes: mechanisms, regulation, and biological significance , 2004, Protoplasma.
[6] S. Werner,et al. Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.
[7] A. Watkinson. Stratum corneum thiol protease (SCTP): a novel cysteine protease of late epidermal differentiation , 1999, Archives of Dermatological Research.
[8] J. S. Rao,et al. Molecular mechanisms of glioma invasiveness: the role of proteases , 2003, Nature Reviews Cancer.
[9] Bonnie F. Sloane,et al. Cysteine cathepsins: multifunctional enzymes in cancer , 2006, Nature Reviews Cancer.
[10] J. Hornung,et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.
[11] Neil D. Rawlings,et al. MEROPS: the protease database , 2002, Nucleic Acids Res..
[12] N. Fusenig,et al. HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. , 2004, European Journal of Cell Biology.
[13] J. Rheinwald,et al. A new small (40 kd) keratin filament protein made by some cultured human squamous cell carcinomas , 1981, Cell.
[14] J. Calvete,et al. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). , 1991, The Journal of biological chemistry.
[15] H. Ford,et al. Cellular, biochemical, and clinical aspects of wound healing. , 2002, Surgical infections.
[16] Bonnie F. Sloane,et al. Pericellular cathepsin B and malignant progression , 2003, Cancer and Metastasis Reviews.
[17] R. R. Bürk. A factor from a transformed cell line that affects cell migration. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Deussing,et al. Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Elaine Fuchs,et al. Getting under the skin of epidermal morphogenesis , 2002, Nature Reviews Genetics.
[20] J. Deussing,et al. Towards Specific Functions of Lysosomal Cysteine Peptidases: Phenotypes of Mice Deficient for Cathepsin B or Cathepsin L , 2001, Biological chemistry.
[21] J. Mort,et al. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. , 1998, The Biochemical journal.
[22] Bonnie F. Sloane,et al. Phorbol ester activation of a proteolytic cascade capable of activating latent TGF-β: A process initiated by the exocytosis of cathepsin B , 2002 .
[23] N. Fusenig,et al. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-α , 2003, Journal of Cell Science.
[24] Bonnie F. Sloane,et al. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. , 2000, Biochimica et biophysica acta.
[25] L. Simonetti,et al. Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin l2. , 2003, The Journal of investigative dermatology.
[26] R. W. Holley,et al. Migration of mouse 3T3 fibroblasts in response to a serum factor. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[27] G Murphy,et al. Proteolysis and cell migration: creating a path? , 1999, Current opinion in cell biology.
[28] Bonnie F. Sloane,et al. Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-β , 2002, The Journal of Biological Chemistry.
[29] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[30] P. Friedl. Prespecification and plasticity: shifting mechanisms of cell migration. , 2004, Current opinion in cell biology.
[31] D. Turk,et al. Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft. , 2004, The Biochemical journal.
[32] Bonnie F. Sloane,et al. Degradation of laminin by human tumor cathepsin B , 1989, Clinical & Experimental Metastasis.
[33] B. Wiederanders,et al. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile , 1998, Journal of Cancer Research and Clinical Oncology.
[34] K. Tomoo,et al. Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor. , 1992, Journal of molecular biology.
[35] L. Creemers,et al. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling , 1996, The Histochemical Journal.
[36] Y. Hata,et al. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex. , 1997, Journal of biochemistry.
[37] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[38] K. Brix,et al. Watching proteases in action , 2005, Nature chemical biology.
[39] I. Assfalg-Machleidt,et al. Epoxysuccinyl peptide‐derived affinity labels for cathepsin B , 2000, FEBS letters.
[40] M. Pagano,et al. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin. , 1993, Biological chemistry Hoppe-Seyler.
[41] H. Chapman,et al. Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.
[42] A. Barrett,et al. CA074 methyl ester: a proinhibitor for intracellular cathepsin B. , 1992, Archives of biochemistry and biophysics.
[43] Nils Brünner,et al. The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin , 2001, The Journal of cell biology.
[44] D. Schmitt,et al. Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines , 2004, Clinical & Experimental Metastasis.
[45] I. Assfalg-Machleidt,et al. Substrate/propeptide‐derived endo‐epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors , 1998, FEBS letters.
[46] A. Baici,et al. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases , 1999, FEBS letters.
[47] Peter Friedl,et al. Functional imaging of pericellular proteolysis in cancer cell invasion. , 2005, Biochimie.
[48] H. Chapman,et al. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. , 1997, Current opinion in cell biology.
[49] Elaine Fuchs,et al. Stem cells of the skin epithelium , 2003, Proceedings of the National Academy of Sciences of the United States of America.